My watch list
my.bionity.com  
Login  
NEWS
Current news

Smarter drug release thanks to control over encapsulation

21-Mar-2019 Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients. Moreover, designing encapsulations for new drugs will now require fa ... more

CRISPR/Cas libraries open new avenues in cancer research

Innovative methods lead to foundation of start-up Vivlion GmbH

21-Mar-2019 CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for exa ... more

New technique for in-cell distance determination

21-Mar-2019 Researchers from the University of Konstanz, Bielefeld University and ETH Zurich demonstrate for the first time that the pulsed EPR technique RIDME (relaxation-induced dipolar modulation enhancement) can be used for in-cell distance determination in biomacromolecules. Applied within the cel ... more

Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Collaboration to build global-standard platform for plasmid and virus manufacturing in China

20-Mar-2019 Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing. “Manufacturing of high-quality plasmid and viral vectors is one of the most critical components in the ... more

Organoids reveal inflammatory processes in chlamydia infections

Researchers discover how bacteria could promote inflammation and the development of ovarian cancer

20-Mar-2019 For a long time, researchers were only able to examine human cells infected with bacteria by using cancer cell lines. However, these transformed cells often give a false impression of the infection process. Fallopian tube organoids from normal human fallopian tube cells, on the other hand, ... more

Evotec and GARDP announce new partnership to discover novel antibiotics

20-Mar-2019 Evotec AG and The Global Antibiotic Research and Development Partnership (“GARDP”) are announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance (“AMR”). By joining forces, Evotec and GARDP will leverage their capabilitie ... more

Big Data against hepatitis

20-Mar-2019 An extremely fast reproducing virus variant is to blame for the therapy resistance of hepatitis E. Still, it has now helped researchers create a cell culture model. As far as research is concerned, hepatitis E (HEV) had long led a shadowy existence – even though it is the main cause for acu ... more

Biologists develop new method of cloning

High efficiency at low cost

19-Mar-2019 DNA, which contains the genetic information of an organism, consists of long “chains” of nucleotides. In order to study the functions based on the sequence of these building blocks, DNA molecules must be inserted in carrier molecules (plasmid-vectors) to be multiplied. For this cloning proc ... more

Duplicate or mirror? Laser light determines chirality of molecules

19-Mar-2019 Seven of the ten most frequent medications contain chiral agents. These are molecules that occur in right- or left-handed forms. During chemical synthesis both forms usually occur in equal parts and have to be separated afterward, because chirality determines the agent’s effect in the body. ... more

New Potential Approach to Treat Atopic Dermatitis

19-Mar-2019 How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of atopic dermatitis. An antibody therapy could alleviate this chronic in ... more

All news

New technique for in-cell distance determination

21-Mar-2019 Researchers from the University of Konstanz, Bielefeld University and ETH Zurich demonstrate for the first time that the pulsed EPR technique RIDME (relaxation-induced dipolar modulation enhancement) can be used for in-cell distance determination in biomacromolecules. Applied within the cel ... more

Tiny “blinkers” reveal molecules inside cells

18-Mar-2019 LMU physicists led by Ralf Jungmann introduce an entirely new approach to super-resolution microscopy: Tiny ‘blinkers’ enable simultaneous imaging of multiple biomolecules. In everyday life, blinking lights can send signals – for example, that a car is going to turn. Now, researchers have e ... more

On-the-spot genome analysis

15-Mar-2019 The ability to read the genome - all the DNA of an organism - has vast potential to understand human health and disease. Researchers at the Garvan Institute of Medical Research and UNSW Sydney have published a method to take genome analysis 'offline', by adapting a computer algorithm that c ... more

Copying Made Easy: A universal isothermal DNA amplification method

14-Mar-2019 Whether revealing a perpetrator with DNA evidence, diagnosing a pathogen, classifying a paleontological discovery, or determining paternity, the duplication of nucleic acids (amplification) is indispensable. In the journal Angewandte Chemie, scientists have now introduced a new, very simple ... more

Illuminating the genome

RNA-guided endonuclease - in situ labelling, a new CRISPR/Cas9 based molecular visualisation method

12-Mar-2019 The CRISPR/Cas9 system has been making ripples in the scientific community ever since its mechanisms were proposed in 2012. Commonly referred to as a genome editing tool, many scientists have found different applications for the scissor-like properties of the Cas9-protein. Researchers from ... more

Decoding Lil BUB: Crowdfunded project reveals genome of internet celebrity cat

06-Mar-2019 Lil BUB has drawn millions of followers across the internet for her cute appearance. Behind the celebrity cat’s unique features is a combination of two rare genetic variants, three molecular biologists from Germany and the US report. The results of their crowdfunded project “LilBUBome” are ... more

Cell atlas of the aging lung

01-Mar-2019 Aging promotes lung function decline and increases susceptibility to diseases of the respiratory tract. In order to understand these effects in detail, researchers at Helmholtz Zentrum München, a partner in the German Center for Lung Research (DZL), analyzed the aging process in the lung at ... more

KNAUER among the top one percent of employers in Germany

28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

Growth factors in single cells counted for the first time

26-Feb-2019 Whether healthy or diseased, human cells exhibit behaviors and processes that are largely dictated by growth factor molecules, which bind to receptors on the cells. For example, growth factors tell the cells to divide, move, and when to die--a process known as apoptosis. When growth factor ... more

Thomas Heydler appointed to the Supervisory Board of Eppendorf AG

22-Feb-2019 Thomas Heydler has been a member of the Supervisory Board of Eppendorf AG since January 25, 2019. He succeeds Dr. Michael Schroeder, who resigned for personal reasons. "With Thomas Heydler, we have succeeded in gaining another very experienced manager for the Eppendorf Supervisory Board. We ... more

All news on bioanalytics

CRISPR/Cas libraries open new avenues in cancer research

Innovative methods lead to foundation of start-up Vivlion GmbH

21-Mar-2019 CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for exa ... more

Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Collaboration to build global-standard platform for plasmid and virus manufacturing in China

20-Mar-2019 Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing. “Manufacturing of high-quality plasmid and viral vectors is one of the most critical components in the ... more

Biologists develop new method of cloning

High efficiency at low cost

19-Mar-2019 DNA, which contains the genetic information of an organism, consists of long “chains” of nucleotides. In order to study the functions based on the sequence of these building blocks, DNA molecules must be inserted in carrier molecules (plasmid-vectors) to be multiplied. For this cloning proc ... more

Speed limit on DNA-making sets pace for life's first steps

15-Mar-2019 Fruit flies make for stingy mothers, imparting only a portion of the genetic building blocks their offspring need to survive. The rest must be produced by the fertilized egg in its first few steps of growth. Scientists puzzled for two decades over this seemingly unnecessary withholding. Now ... more

Researchers create nano-bot to probe inside human cells

15-Mar-2019 University of Toronto Engineering researchers have built a set of magnetic 'tweezers' that can position a nano-scale bead inside a human cell in three dimensions with unprecedented precision. The nano-bot has already been used to study the properties of cancer cells, and could point the way ... more

Stress hormones promote breast cancer metastasis

14-Mar-2019 It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones. In addition, they found that synthet ... more

An international study co-led by CNIO identifies a 'sensor' that activates cell migration

13-Mar-2019 The cytoskeleton is a structure that not only helps cells maintain their shape and internal organisation, but also enables them to perform functions like movement and migration, that is to say, the movement that takes cells far from the place where they are initially located. Migration form ... more

For infection-fighting cells, a guideline for expanding the troops

Researchers at Princeton look into the mathematical relationship that describes how T cells expand in response to infection

13-Mar-2019 T cells are like the special ops forces of the immune system, detecting and killing infected cells. When a new threat is detected, the cells ramp up from just a few sentry cells to a full platoon. But how does the immune system make just the right amount of T cells, when the starting popula ... more

Illuminating the genome

RNA-guided endonuclease - in situ labelling, a new CRISPR/Cas9 based molecular visualisation method

12-Mar-2019 The CRISPR/Cas9 system has been making ripples in the scientific community ever since its mechanisms were proposed in 2012. Commonly referred to as a genome editing tool, many scientists have found different applications for the scissor-like properties of the Cas9-protein. Researchers from ... more

The ABS of molecular engines

12-Mar-2019 Peroxisomes are cell organelles that carry out a number of functions, including the degradation of cytotoxins. For this purpose, they require enzymes that have to be transported into peroxisomes via complicated machinery. The team from the research group Biochemistry of Intracellular Transp ... more

All news on biotechnology

Effective through AI in Transplantation Medicine: New Prediction Models for Disease Progression

Project network provides IT platform for clinical data integration, model development and validation

07-Mar-2019 If radiation or chemotherapy treatment of leukaemias or lymphomas does not bring sufficient success, the transplantation of bone marrow or blood stem cells is usually the only chance of cure. Unfortunately, the majority of patients die despite transplantation, often due to spontaneous infec ... more

Protein content as a marker for response to therapy in brain cancer

Look into the future in fact seems possible

06-Mar-2019 Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-inva ... more

Study fails to link phthalates and increased breast cancer risk

Epidemiologist says more research is needed looking at younger women

15-Feb-2019 In the largest study to date on phthalates and postmenopausal breast cancer, a University of Massachusetts Amherst cancer epidemiology researcher found no association between breast cancer risk and exposure to the plasticizing and solvent chemicals used in such common products as shampoo, m ... more

First-hand expertise at the biggest ever analytica Vietnam

14-Feb-2019 analytica Vietnam 2019 in Ho Chi Minh City will be celebrating not just its tenth anniversary but also its biggest trade fair event yet. Approximately 130 exhibitors from 15 countries will be on show in the Saigon Exhibition and Convention Center (SECC) from April 3 to 5, 2019. The exhibiti ... more

Identifying brain protein crucial to recovery from stroke

13-Feb-2019 Every 40 seconds, someone in the United States suffers a stroke and available therapies, such as clot busting drugs or clot removal devices, are focused on limiting the extent of brain damage. Now, research from the University of Pittsburgh School of Medicine and the VA Pittsburgh Healthcar ... more

Mapping oesophageal cancer genes leads to new drug targets

06-Feb-2019 Mutations that cause oesophageal adenocarcinoma (OAC) have been mapped in unprecedented detail - unveiling that more than half could be targeted by drugs currently in trials for other cancer types. This research could help stratify oesophageal cancer patients to give them more personalised ... more

Revealing the path of a metallodrug in a breast cancer cell

05-Feb-2019 Some types of cancer cannot be treated with classical chemotherapy. Scientists from Inserm, CNRS, Sorbonne University, PSL university, University Grenoble Alpes and ESRF, the European Synchrotron, are working on a metallorganic molecule as an antitumor drug. Their research has given thoroug ... more

Aspirin cuts heart attack risk but increases chance of dangerous bleeding

24-Jan-2019 Regular aspirin should not be recommended for preventing heart attack and stroke in people without cardiovascular disease. The researchers, from Imperial’s National Heart and Lung Institute and King's College London, analysed 13 clinical trials – involving more than 164,000 participants – t ... more

Early Prediction of Alzheimer’s Progression in Blood

23-Jan-2019 Years before symptoms of Alzheimer’s disease manifest, the brain starts changing and neurons are slowly degraded. Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tübingen now show that ... more

Achim von Leoprechting promoted to become CEO of Tecan after retirement of David Martyr

22-Jan-2019 The Tecan Group announced the retirement of Tecan CEO Dr David Martyr after 6 1/2 years at the helm of the company. The Board of Directors has appointed Dr Achim von Leoprechting, Head of Tecan's Partnering Business division, as the new Chief Executive Officer. He will assume the CEO role o ... more

All news on diagnostics

New base at the heart of science and industry

LUMITOS AG now calls Germany's largest science and technology park in Berlin-Adlershof its home

04-Mar-2019 At the beginning of the year, LUMITOS AG also physically moved closer to its customer base: the provider of B2B online media and online marketing services for the chemical, life science, laboratory, pharmaceutical, analytics, food and beverage industries relocated its headquarters to the Sc ... more

Thomas Heydler appointed to the Supervisory Board of Eppendorf AG

22-Feb-2019 Thomas Heydler has been a member of the Supervisory Board of Eppendorf AG since January 25, 2019. He succeeds Dr. Michael Schroeder, who resigned for personal reasons. "With Thomas Heydler, we have succeeded in gaining another very experienced manager for the Eppendorf Supervisory Board. We ... more

Shaping light lets 2D microscopes capture 4D data

Invention adds new dimension to fluorescent microscopy

20-Feb-2019 Rice University researchers have added a new dimension to their breakthrough technique that expands the capabilities of standard laboratory microscopes. Two years ago, the Rice lab of chemist Christy Landes introduced super temporal resolution microscopy, a technique that allowed researcher ... more

Charles River Laboratories to acquire French CRO

18-Feb-2019 Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close i ... more

First-hand expertise at the biggest ever analytica Vietnam

14-Feb-2019 analytica Vietnam 2019 in Ho Chi Minh City will be celebrating not just its tenth anniversary but also its biggest trade fair event yet. Approximately 130 exhibitors from 15 countries will be on show in the Saigon Exhibition and Convention Center (SECC) from April 3 to 5, 2019. The exhibiti ... more

Andrew Alliance and Sartorius collaborate to provide software-connected pipettes

12-Feb-2019 Andrew Alliance S.A. and Sartorius announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories. Andrew Alliance, the robotics company with an innovative approach to l ... more

Beckman Coulter strenghtens laboratory automation business

Acquires of acoustic liquid handling company

01-Feb-2019 Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with une ... more

Sartorius increases sales revenue and earnings in 2018 by double digits

Bioprocess Solutions and the Americas especially strong

29-Jan-2019 Sartorius continued on the growth track in 2018 in both divisions and across all geographies, and thus achieved its forecast raised considerably at mid-year. According to preliminary figures, Group sales revenue rose in constant currencies by 13.2% to 1,566.0 million euros (reported: 11.5%) ... more

Sanofi joins digital health focused innovation program Startup Creasphere

24-Jan-2019 Startup Creasphere, the first digital health innovation hub in Europe, has today announced a partnership with the consumer healthcare business unit of Sanofi. Sanofi will partner with Startup Creasphere and other companies in creating the ultimate hub of digital health innovation in Europe, ... more

Novel materials convert visible into infrared light

Penetrate of living tissue and other materials without damage by high-intensity light exposure

18-Jan-2019 Columbia University scientists, in collaboration with researchers from Harvard, have succeeded in developing a chemical process to convert visible light into infrared energy, allowing innocuous radiation to penetrate living tissue and other materials without the damage caused by high-intens ... more

All news on lab technology

Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Collaboration to build global-standard platform for plasmid and virus manufacturing in China

20-Mar-2019 Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing. “Manufacturing of high-quality plasmid and viral vectors is one of the most critical components in the ... more

Evotec and GARDP announce new partnership to discover novel antibiotics

20-Mar-2019 Evotec AG and The Global Antibiotic Research and Development Partnership (“GARDP”) are announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance (“AMR”). By joining forces, Evotec and GARDP will leverage their capabilitie ... more

Duplicate or mirror? Laser light determines chirality of molecules

19-Mar-2019 Seven of the ten most frequent medications contain chiral agents. These are molecules that occur in right- or left-handed forms. During chemical synthesis both forms usually occur in equal parts and have to be separated afterward, because chirality determines the agent’s effect in the body. ... more

Merck cooperates with French start-up

Generative modelling AI technology enables rapid and cost-effective design of novel drugs

15-Mar-2019 Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how we aim t ... more

Novartis announces change in Sandoz leadership

14-Mar-2019 Novartis announced that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019. Francesco Balestrieri, currently Region Head Europe, Sandoz, has been appointed ad-interim CEO Sandoz. He will repor ... more

Purdue researchers develop innovative, more cost-effective method to make drugs

12-Mar-2019 The Food and Drug Administration wants the pharmaceutical industry to get away from making drugs using the traditional batch method and switch to a more modern process known as continuous manufacturing. The FDA put out a statement on Feb. 26 saying the continuous process allows manufacturer ... more

'Undruggable' Parkinson's molecule spills its secrets

Successful pharmacological activation of Nurr1 opens doors to novel therapies for incurable movement disorder

11-Mar-2019 UC San Francisco researchers have for the first time developed a strategy for targeting a key molecule implicated in Parkinson's disease, opening up a potential new treatment strategy for the currently incurable movement disorder. "This molecule is widely regarded as one of the top therapeu ... more

How well do vaccines work? Research reveals measles vaccine efficacy

The recent measles outbreaks across the country emphasize the importance of vaccinations.

11-Mar-2019 "For many infectious diseases, we rely on herd immunity to prevent outbreaks of vaccine-preventable infections. Herd immunity is the protection of the 'herd,' our population, by preventing infections in the vast majority people," said Kate Langwig, an infectious disease ecologist at Virgini ... more

Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance

08-Mar-2019 Procarta Biosystems, a privately held UK-based biotech company, announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR). The new funding will be used to develop a pipeline of an entirely new ... more

Merck Achieves 2018 Targets and Is Set for Profitable Growth

07-Mar-2019 Merck posted a successful finish to a challenging 2018. Net sales increased over the previous year, whereas EBITDA pre declined sharply owing to strong foreign exchange effects. Organically, this key earnings indicator was only slightly lower than in 2017. Merck wants to keep the dividend s ... more

All news on pharma

Smarter drug release thanks to control over encapsulation

21-Mar-2019 Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients. Moreover, designing encapsulations for new drugs will now require fa ... more

CRISPR/Cas libraries open new avenues in cancer research

Innovative methods lead to foundation of start-up Vivlion GmbH

21-Mar-2019 CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for exa ... more

Organoids reveal inflammatory processes in chlamydia infections

Researchers discover how bacteria could promote inflammation and the development of ovarian cancer

20-Mar-2019 For a long time, researchers were only able to examine human cells infected with bacteria by using cancer cell lines. However, these transformed cells often give a false impression of the infection process. Fallopian tube organoids from normal human fallopian tube cells, on the other hand, ... more

Big Data against hepatitis

20-Mar-2019 An extremely fast reproducing virus variant is to blame for the therapy resistance of hepatitis E. Still, it has now helped researchers create a cell culture model. As far as research is concerned, hepatitis E (HEV) had long led a shadowy existence – even though it is the main cause for acu ... more

New Potential Approach to Treat Atopic Dermatitis

19-Mar-2019 How does the immune system respond to fungi on our skin? Researchers at the University of Zurich have demonstrated that the same immune cells that protect us against skin fungi also encourage the inflammatory symptoms of atopic dermatitis. An antibody therapy could alleviate this chronic in ... more

Scientists identify compounds in coffee which may inhibit prostate cancer

19-Mar-2019 For the first time, scientists have identified compounds found in coffee which may inhibit the growth of prostate cancer. This is a pilot study, carried out on drug-resistant cancer cells in cell culture and in a mouse model; it has not yet been tested in humans. This work is presented at t ... more

Healthy Ageing: Age-Related Protein Modifications in Cells Are Quantifiable

18-Mar-2019 An international team of researchers was able to produce proteins that enable the exact measurement of modified lysines in cells. Modified lysines play an important role in the development of severe illnesses and for a healthy ageing process. We would all like to be and remain healthy in la ... more

From mirror-image biology to enhanced therapeutic proteins

18-Mar-2019 Scientists from the German Cancer Research Center (DKFZ) have succeeded in reconstructing biomolecules in their mirror-image form. The researchers' goal is to create a mirror-image artificial protein synthesis system. Their aim is to produce mirror-image therapeutic proteins, such as antibo ... more

Stress hormones promote breast cancer metastasis

14-Mar-2019 It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones. In addition, they found that synthet ... more

Lab grown ‘brains’ successfully model disease

14-Mar-2019 Scientists were able to model a developmental disorder called neuronal heterotopia which can lead to intellectual disability and epilepsy. They used a model of brain development called brain organoids where human cells organize themselves in the petri dish into brain-like structures. Brain ... more

All news on healthcare
News by department
  • Products

    Merck cooperates with French start-up

    Generative modelling AI technology enables rapid and cost-effective design of novel drugs

    15-Mar-2019 Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how we aim t ... more

    Potential New Treatment for Heart Attack

    Prospective drug found by testing in human heart muscle grown from stem cells

    11-Mar-2019 Domainex announced that a team of its scientists, working in close partnership with Professor Michael Schneider and his team at Imperial College, have found a potential new drug candidate for treating the heart damage caused during a heart attack by targeting the way the heart reacts to str ... more

    Evotec receives milestone payment for start of second Phase II trial in its multi-target alliance with Bayer

    01-Mar-2019 Evotec AG announced that another promising small molecule from its multi-target alliance with Bayer has advanced into Phase II clinical development for the treatment of persistent chronic cough. As a result of the trial initiation, Evotec received a payment of € 3 m. In October 2012, Evotec ... more

  • Business

    Metrohm and B&W Tek to take Raman spectroscopy to the next level

    18-Mar-2019 The acquisition of B&W Tek LLC by Swiss Metrohm AG in July 2018 creates one of the largest solution providers for applied Raman spectroscopy. Two technology leaders in the field of Raman spectroscopy join forces, and customers all over the world will benefit: That is the key message that Me ... more

    New base at the heart of science and industry

    LUMITOS AG now calls Germany's largest science and technology park in Berlin-Adlershof its home

    04-Mar-2019 At the beginning of the year, LUMITOS AG also physically moved closer to its customer base: the provider of B2B online media and online marketing services for the chemical, life science, laboratory, pharmaceutical, analytics, food and beverage industries relocated its headquarters to the Sc ... more

    Northern Swan invests millions in pharma startup Cansativa

    New Milestone for Cansativa Towards “EU GxP Innovation Hub”

    01-Mar-2019 Northern Swan, a New-York based investment firm, has invested several million euros in Cansativa GmbH, in order to further accelerate the growth of the company and its integration into the wider European market. Cansativa will use this investment to expand its current facilities to become a ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Smarter drug release thanks to control over encapsulation

    21-Mar-2019 Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs. This gives more control over the slow and steady release of drugs in patients. Moreover, designing encapsulations for new drugs will now require fa ... more

    CRISPR/Cas libraries open new avenues in cancer research

    Innovative methods lead to foundation of start-up Vivlion GmbH

    21-Mar-2019 CRISPR/Cas enables the targeted deactivation of genes by cutting DNA at pre-determined sites. This is accomplished by providing the Cas enzyme with a genetic zip code. Using an entire library of zip codes, it is then possible to simultaneously probe multiple sites within the genome, for exa ... more

    New technique for in-cell distance determination

    21-Mar-2019 Researchers from the University of Konstanz, Bielefeld University and ETH Zurich demonstrate for the first time that the pulsed EPR technique RIDME (relaxation-induced dipolar modulation enhancement) can be used for in-cell distance determination in biomacromolecules. Applied within the cel ... more

  • People

    Novartis announces change in Sandoz leadership

    14-Mar-2019 Novartis announced that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019. Francesco Balestrieri, currently Region Head Europe, Sandoz, has been appointed ad-interim CEO Sandoz. He will repor ... more

    Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment

    27-Feb-2019 Lonza announced the internal alignment of its business structure to accelerate growth along the Healthcare Continuum® and strengthen the Microbial Control business. Stefan Stoffel has been appointed to a new role on the Executive Committee as COO, Lonza Pharma Biotech & Nutrition (LPBN), re ... more

    Thomas Heydler appointed to the Supervisory Board of Eppendorf AG

    22-Feb-2019 Thomas Heydler has been a member of the Supervisory Board of Eppendorf AG since January 25, 2019. He succeeds Dr. Michael Schroeder, who resigned for personal reasons. "With Thomas Heydler, we have succeeded in gaining another very experienced manager for the Eppendorf Supervisory Board. We ... more

  • Finances

    Procarta announces €1.5 million investment for new class of antibiotics to combat antimicrobial resistance

    08-Mar-2019 Procarta Biosystems, a privately held UK-based biotech company, announced €1.5m of new funding from the Novo Holdings REPAIR Impact Fund to support development of novel therapies to combat antimicrobial resistance (AMR). The new funding will be used to develop a pipeline of an entirely new ... more

    Merck Achieves 2018 Targets and Is Set for Profitable Growth

    07-Mar-2019 Merck posted a successful finish to a challenging 2018. Net sales increased over the previous year, whereas EBITDA pre declined sharply owing to strong foreign exchange effects. Organically, this key earnings indicator was only slightly lower than in 2017. Merck wants to keep the dividend s ... more

    Charles River Laboratories to acquire French CRO

    18-Feb-2019 Charles River Laboratories International, Inc. announced that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing adjustments. The proposed transaction is expected to close i ... more

  • Cooperation

    Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

    Collaboration to build global-standard platform for plasmid and virus manufacturing in China

    20-Mar-2019 Merck announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing. “Manufacturing of high-quality plasmid and viral vectors is one of the most critical components in the ... more

    Evotec and GARDP announce new partnership to discover novel antibiotics

    20-Mar-2019 Evotec AG and The Global Antibiotic Research and Development Partnership (“GARDP”) are announcing the formation of a new strategic public-private partnership to tackle the growing threat of antimicrobial resistance (“AMR”). By joining forces, Evotec and GARDP will leverage their capabilitie ... more

    Merck cooperates with French start-up

    Generative modelling AI technology enables rapid and cost-effective design of novel drugs

    15-Mar-2019 Merck announced a collaboration agreement with Iktos, for the use of its generative modelling artificial intelligence (AI) technology, in order to facilitate the rapid and cost-effective discovery and design of promising new compounds. “This agreement is another illustration of how we aim t ... more

  • Technology

    BioMCN to produce renewable methanol with green hydrogen

    27-Feb-2019 Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently inves ... more

    Growth factors in single cells counted for the first time

    26-Feb-2019 Whether healthy or diseased, human cells exhibit behaviors and processes that are largely dictated by growth factor molecules, which bind to receptors on the cells. For example, growth factors tell the cells to divide, move, and when to die--a process known as apoptosis. When growth factor ... more

    Scientists sharpen their molecular scissors and expand the gene editing toolbox

    26-Feb-2019 Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have figured out a better way to deliver a DNA editing tool to shorten the presence of the editor proteins in the cells in what they describe as a "hit and run" approach. CRISPR (clustered regularly interspaced short palindr ... more

  • Laws

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

  • Market

    Lonza to Establish Strategic Biomanufacturing Base in China

    13-Dec-2018 Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be final ... more

    SOPAT GmbH and Malvern Panalytical announce a distribution agreement for US market

    09-Oct-2018 SOPAT GmbH announced a distribution agreement with Malvern Panalytical. Malvern Panalytical is now the exclusive distributor for a complete range of SOPAT photo-optical image analysis instrumentation and software in the United States of America. “We are thrilled to be working together with ... more

    Catalent Invests $7.3 Million in Italy

    Expands Softgel Encapsulation and Packaging Capabilities in Support of Consumer Health

    08-Oct-2018 Catalent Pharma Solutions announced that it had completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy. The first phase of investment, completed in August 2018, saw the expansion and ... more

  • Politics

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

  • Manufacturing

    BioMCN to produce renewable methanol with green hydrogen

    27-Feb-2019 Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently inves ... more

    SCHOTT to invest 300 million euros in pharmaceutical packaging business

    Group to build new production facilities in Germany and China and expand capacity in India and Switzerland

    18-Jan-2019 The SCHOTT technology group is set to invest around 300 million euros in the next three years in the expansion of its core business of glass tubing as the starting material for pharmaceutical packaging as well as pharmaceutical packaging made of glass and polymer, reinforcing its strong bel ... more

    Lonza to Establish Strategic Biomanufacturing Base in China

    13-Dec-2018 Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be final ... more

  • Career

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

    Merck Named a Global Top Employer

    07-Feb-2019 Merck announced it has been named one of only 14 global employers of choice by the Top Employers Institute. The annual Global Top Employer certification recognizes companies that have shown excellence in people practices and structures worldwide. Merck has been awarded this certification fo ... more

    Agilent and University of Duisburg-Essen Announce Collaboration Agreement

    New Teaching and Research Center for Separation

    28-May-2018 Agilent Technologies Inc. and the University of Duisburg-Essen has formed a collaboration agreement that brings together Agilent's leading analytical technologies with the University's outstanding researchers. As part of the collaboration, Agilent will support the university with a broad ra ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE